Testing a new antibody to prevent tetanus
Part of Infections clinical trials.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You weigh at least 110 pounds (for women) or 132 pounds (for men) and have a healthy body weight relative to your height.
- You are not allergic to the study drug or similar medicines.
- You haven't had a tetanus shot or tetanus infection in the past 10 years.
- You don't have long-term infections like hepatitis B or C, or HIV.
- You are willing to avoid pregnancy or fathering a child during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection (SNA02-48) designed to protect adults who are at high risk of tetanus infection. Tetanus is a serious bacterial infection that can cause severe muscle stiffness and life-threatening complications; this study evaluates whether this new protective treatment is safe and effective.
This trial tests a new medicine called GR2001 to help prevent tetanus after a dirty wound. It is for people who have not had many tetanus shots before and need extra protection.
This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.
This study looks at how well a tetanus booster vaccine works by testing your saliva and blood. It includes healthy children, young adults, pregnant women, and adults with certain medical conditions.
This study tests a new type of patch with tiny needles (microneedles) that delivers a tetanus vaccine booster through your skin instead of a traditional injection. Researchers want to confirm it's safe and works well in healthy adults.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.